Unknown PHASE2 INTERVENTIONAL 3-arm NCT04149626

Dexmedetomidine Sedation in Orthopedic Surgery

Prospective, Randomized Comparative Study of Intravenous Dexmedetomidine for Sedation in Orthopedic Surgery Under Regional Anesthesia

Sponsor: Asklepieion Voulas General Hospital

Conditions Hallux Valgus and Bunion Sedation

Interventions Dexmedetomidine Midazolam Remifentanil

Updated 6 times since 2019 Last updated: Jan 28, 2020 Started: Jan 29, 2020 Primary completion: Dec 31, 2021 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04149626, this PHASE2 trial focuses on Hallux Valgus and Bunion and Sedation and remains ongoing. Sponsored by Asklepieion Voulas General Hospital, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jul 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Jul 2022 [monthly]

Recruiting PHASE2
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Dec 2019 — Feb 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asklepieion Voulas General Hospital
Chryssoula Staikou
Maria Tileli

Data source: Asklepieion Voulas General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece